T2 BIOSYSTEMS INC's ticker is TTOO and the CUSIP is 89853L104. A total of 57 filers reported holding T2 BIOSYSTEMS INC in Q4 2016. The put-call ratio across all filers is 0.93 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $180,000 | +10.4% | 68,317 | +25.9% | 0.00% | – |
| Q4 2018 | $163,000 | -87.9% | 54,265 | -69.9% | 0.00% | – |
| Q3 2018 | $1,342,000 | +82.1% | 180,130 | +89.2% | 0.00% | – |
| Q2 2018 | $737,000 | +242.8% | 95,192 | +132.4% | 0.00% | – |
| Q1 2017 | $215,000 | -3.6% | 40,967 | -3.2% | 0.00% | – |
| Q4 2016 | $223,000 | -21.5% | 42,335 | +7.8% | 0.00% | – |
| Q3 2016 | $284,000 | -8.4% | 39,289 | 0.0% | 0.00% | – |
| Q2 2016 | $310,000 | -9.1% | 39,289 | +13.5% | 0.00% | – |
| Q1 2016 | $341,000 | 0.0% | 34,623 | +10.9% | 0.00% | – |
| Q4 2015 | $341,000 | +68.0% | 31,206 | +34.8% | 0.00% | – |
| Q3 2015 | $203,000 | -46.0% | 23,152 | 0.0% | 0.00% | – |
| Q2 2015 | $376,000 | -14.2% | 23,152 | -17.9% | 0.00% | – |
| Q1 2015 | $438,000 | -19.3% | 28,206 | 0.0% | 0.00% | – |
| Q4 2014 | $543,000 | +130.1% | 28,206 | +116.2% | 0.00% | – |
| Q3 2014 | $236,000 | – | 13,049 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,841,924 | $13,722,000 | 6.87% |
| Senvest Management, LLC | 2,769,931 | $20,636,000 | 1.56% |
| Bell Rock Capital LLC | 291,835 | $2,176,000 | 1.07% |
| ARDSLEY ADVISORY PARTNERS LP | 935,000 | $6,966,000 | 0.94% |
| TIGER MANAGEMENT L.L.C. | 967,585 | $7,209,000 | 0.72% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 677,433 | $5,047,000 | 0.59% |
| THOMPSON DAVIS & CO., INC. | 33,153 | $247,000 | 0.54% |
| PERKINS CAPITAL MANAGEMENT INC | 69,700 | $519,000 | 0.31% |
| Schonfeld Strategic Advisors LLC | 322,700 | $2,404,000 | 0.11% |
| Phoenix Investment Adviser LLC | 8,000 | $60,000 | 0.08% |